CTOs on the Move

Caregiver

www.cg-idd.com

 
Caregiver, Inc. is one of the largest providers of support services to people with intellectual and developmental disabilities and traumatic brain injury in the United States. We currently operate in Texas and Tennessee under multiple local brands, including: Daybreak Community Services Unified Care Group Southern Concepts River Gardens St. Giles Omni Support Services/Caregiver of Tennessee Our Mission is "Enabling people with intellectual and developmental disabilities to lead their unique lives with dignity, independence and inclusion." We believe in recruiting, training and developing the best people to support the individuals we serve; enabling them with tools and technology to provide individualized ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.cg-idd.com
  • 4800 Overton Plaza Suite 440
    Fort Worth, TX USA 76109
  • Phone: 800.299.5161

Executives

Name Title Contact Details
John Beauchamp
Vice President Information Technology Profile

Funding

Caregiver raised $82M on 04/03/2019

Similar Companies

The Turnaround Team

The Turnaround Team is a Westfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Honor Care

Honor is changing the way we care for our parents. Founded in 2014, the San Francisco–based company brings workforce management and technology expertise together with high-touch, personalized care to improve the in-home care experience. Since launching the Honor Care Network in 2017, Honor has partnered with a growing roster of independently owned home care agencies to deliver reliable, transparent, and high-quality care. The Honor Care Network currently provides non-medical home care services to families in more than 800 cities and towns across the United States.

NetMD Business

NetMD Business is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Assembly Biosciences

Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.

VTS Medical Systems

VTS Medical Systems is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.